GlassScriptPhysician profile
Jerrold S Gertzman
NPI 1194799106
$2,083.87
in general payments reported to CMS, 2019-2025
21 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $145 · 2021: $122 · 2022: $476 · 2023: $390 · 2024: $281 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $696.46 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $314.17 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $280.32 | 2019-2025 | Farxiga, Breztri |
| Lilly USA, LLC | $104.58 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Merck Sharp & Dohme LLC | $87.30 | 2019-2025 | Lagevrio, M-M-R II, Capvaxive |
| Amarin Pharma, INC. | $82.83 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.14 | 2022-2024 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $58.32 | 2019-2024 | Shingrix |
| Exact Sciences Corporation | $53.41 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $48.77 | 2019-2024 | Xarelto |
| Idorsia Pharmaceuticals US INC | $47.06 | 2022-2023 | Quviviq |
| Allergan, INC. | $40.67 | 2019-2020 | |
| Abbott Laboratories | $39.91 | 2019-2022 | |
| Dexcom, INC. | $32.41 | 2023 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $26.99 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $26.70 | 2022 | |
| Sanofi Pasteur INC. | $24.90 | 2024 | |
| Phathom Pharmaceuticals, INC. | $14.66 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $14.18 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.94 | 2022 | |
| Abbvie INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerrold Gertzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.